Literature DB >> 16479408

Imaging in cancer therapy and drug development.

Giovanni Lucignani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16479408     DOI： 10.1007/s00259-006-1988-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  7 in total

1.  L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy.

Authors:  Anca-Ligia Grosu; Wolfgang A Weber; Eva Riedel; Branislav Jeremic; Carsten Nieder; Martina Franz; Hartmut Gumprecht; Ruprecht Jaeger; Markus Schwaiger; Michael Molls
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-01       Impact factor: 7.038

2.  Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy.

Authors:  Betty S Pio; Cecilia K Park; Richard Pietras; Wei-Ann Hsueh; Nagichettiar Satyamurthy; Mark D Pegram; Johannes Czernin; Michael E Phelps; Daniel H S Silverman
Journal:  Mol Imaging Biol       Date:  2006 Jan-Feb       Impact factor: 3.488

3.  2-[11C]thymidine positron emission tomography reproducibility in humans.

Authors:  Paula Wells; Roger N Gunn; Colin Steel; Alex S Ranicar; Frank Brady; Safiye Osman; Terry Jones; Pat Price
Journal:  Clin Cancer Res       Date:  2005-06-15       Impact factor: 12.531

4.  Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma.

Authors:  Laurence Moureau-Zabotto; Emmanuel Touboul; Delphine Lerouge; Elisabeth Deniaud-Alexandre; Dany Grahek; Jean-Noël Foulquier; Yolande Petegnief; Benoît Grès; Hanna El Balaa; Kaldoun Kerrou; Françoise Montravers; Katia Keraudy; Emmanuel Tiret; Jean-Pierre Gendre; Jean-Didier Grange; Sidney Houry; Jean-Noël Talbot
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-01       Impact factor: 7.038

5.  Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.

Authors:  Anca L Grosu; Wolfgang A Weber; Martina Franz; Sibylle Stärk; Morand Piert; Reinhard Thamm; Hartmut Gumprecht; Markus Schwaiger; Michael Molls; Carsten Nieder
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-01       Impact factor: 7.038

6.  Positron emission tomography in patients with breast cancer using (18)F-3'-deoxy-3'-fluoro-l-thymidine ((18)F-FLT)-a pilot study.

Authors:  L B Been; P H Elsinga; J de Vries; D C P Cobben; P L Jager; H J Hoekstra; A J H Suurmeijer
Journal:  Eur J Surg Oncol       Date:  2005-11-02       Impact factor: 4.424

7.  Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods.

Authors:  Laura M Kenny; David M Vigushin; Adil Al-Nahhas; Safiye Osman; Sajinder K Luthra; Sami Shousha; R Charles Coombes; Eric O Aboagye
Journal:  Cancer Res       Date:  2005-11-01       Impact factor: 12.701
  7 in total
  1 in total

1.  A novel in vitro assay to assess phosphorylation of 3'-[(18)F]fluoro-3'-deoxythymidine.

Authors:  Ning Guo; Jingping Xie; H Charles Manning; Natasha G Deane; M Sib Ansari; Robert J Coffey; John Gore; Ronald R Price; Ronald M Baldwin; J Oliver McIntyre
Journal:  Mol Imaging Biol       Date:  2011-04       Impact factor: 3.488
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.